Zimmer Biomet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zimmer Biomet and other ETFs, options, and stocks.

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. 

CEO
Ivan Tornos
CEOIvan Tornos
Employees
17,000
Employees17,000
Headquarters
Warsaw, Indiana
HeadquartersWarsaw, Indiana
Founded
1927
Founded1927
Employees
17,000
Employees17,000

ZBH Key Statistics

Market cap
19.25B
Market cap19.25B
Price-Earnings ratio
27.74
Price-Earnings ratio27.74
Dividend yield
0.98%
Dividend yield0.98%
Average volume
2.01M
Average volume2.01M
High today
$101.31
High today$101.31
Low today
$98.30
Low today$98.30
Open price
$100.00
Open price$100.00
Volume
2.82M
Volume2.82M
52 Week high
$114.44
52 Week high$114.44
52 Week low
$84.59
52 Week low$84.59

Stock Snapshot

As of today, Zimmer Biomet(ZBH) shares are valued at $98.44. The company's market cap stands at 19.25B, with a P/E ratio of 27.74 and a dividend yield of 97.5%.

As of 2026-02-28, Zimmer Biomet(ZBH) stock has fluctuated between $98.30 and $101.31. The current price stands at $98.44, placing the stock +0.1% above today's low and -2.8% off the high.

The Zimmer Biomet(ZBH)'s current trading volume is 2.82M, compared to an average daily volume of 2.01M.

In the last year, Zimmer Biomet(ZBH) shares hit a 52-week high of $114.44 and a 52-week low of $84.59.

In the last year, Zimmer Biomet(ZBH) shares hit a 52-week high of $114.44 and a 52-week low of $84.59.

ZBH News

TipRanks 16h
Zimmer Biomet’s New Knee Implant Study Builds a Quiet Catalyst for Long-Term Growth

Zimmer Biomet Holdings (ZBH) announced an update on their ongoing clinical study. Zimmer Biomet’s new clinical study, officially titled “A Prospective, Multi-C...

TipRanks 16h
Zimmer Biomet’s ROSA Knee v1.5 Pilot Study: What the Latest Update Signals for ZBH Investors

Zimmer Biomet Holdings (ZBH) announced an update on their ongoing clinical study. The ROSA® Knee System V1.5 Pilot Study is a single-site clinical project run...

Simply Wall St 2d
Zimmer Biomet Showcases Robotics And Smart Implants At AAOS 2026 Event

Zimmer Biomet Holdings (NYSE:ZBH) plans to showcase advanced orthopedic technologies at AAOS 2026. The lineup includes FDA-cleared robotics, AI-supported navig...

Zimmer Biomet Showcases Robotics And Smart Implants At AAOS 2026 Event

Analyst ratings

56%

of 32 ratings
Buy
31.3%
Hold
56.3%
Sell
12.5%

More ZBH News

Simply Wall St 4d
Zimmer Biomet Valuation Check After Recent Share Price Momentum And Mixed Long Term Returns

Advertisement Zimmer Biomet Holdings stock: why investors are watching now Zimmer Biomet Holdings (ZBH) has caught investor attention after a month that inclu...

Zimmer Biomet Valuation Check After Recent Share Price Momentum And Mixed Long Term Returns

People also own

Based on the portfolios of people who own ZBH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.